Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net income	$ 188,535	$ 194,392
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	131,028	115,435
Share-based compensation	12,168	8,574
Excess tax benefits from share-based compensation	(46)	(182)
Other operating activities, including changes in operating assets and liabilities	(267,769)	(359,046)
Net cash provided by (used in) operating activities	63,916	(40,827)
Investing activities:
Purchases of property, plant and equipment	(97,552)	(119,840)
Proceeds from sale of property, plant and equipment	14,592	15,814
Acquisitions of businesses	(13,797)	(74,127)
Proceeds from divestitures of businesses	6,282	0
Other investing activities	(2,435)	23,335
Net cash used in investing activities	(92,910)	(154,818)
Financing activities:
Proceeds from debt	254,755	20,011
Payments on debt	(300,258)	(522,352)
Net proceeds of commercial paper	263,541	772,108
Shares issued from employee incentive plans	(304)	(502)
Dividends paid	(141,746)	(134,355)
Other financing activities	(19,275)	(6,168)
Net cash provided by financing activities	56,713	128,742
Effect of exchange rate changes on cash and cash equivalents	(4,875)	7,359
Net increase (decrease) in cash and cash equivalents	22,844	(59,544)
Cash and cash equivalents at beginning of period	477,179	479,991
Cash and cash equivalents at end of period	$ 500,023	$ 420,447